Advertisement

Topics

"XFRA DELETION INSTRUMENTS FROM XETRA 2017" Drugs and Medication Database

10:43 EST 25th February 2018 | BioPortfolio

Here are the most relevant "XFRA DELETION INSTRUMENTS FROM XETRA 2017" Drugs and Medications that we have found in our database.

More Information about "XFRA DELETION INSTRUMENTS FROM XETRA 2017" on BioPortfolio

We have published hundreds of XFRA DELETION INSTRUMENTS FROM XETRA 2017 news stories on BioPortfolio along with dozens of XFRA DELETION INSTRUMENTS FROM XETRA 2017 Clinical Trials and PubMed Articles about XFRA DELETION INSTRUMENTS FROM XETRA 2017 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of XFRA DELETION INSTRUMENTS FROM XETRA 2017 Companies in our database. You can also find out about relevant XFRA DELETION INSTRUMENTS FROM XETRA 2017 Drugs and Medications on this site too.

Showing "XFRA DELETION INSTRUMENTS FROM XETRA 2017" Drugs and Medications, all 6

Possibly Relevant

Retavase [EKR Therapeutics, Inc.]

Retavase Reteplase, recombinant

Revlimid [Celgene Corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules Initial U.S. Approval: 2005

Gleevec [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Gleevec   safely and effectively. See full prescribing information for Gleevec . GLEEVEC (imatinib mesylate) tablets for oral use Initial U.S. A

Gleevec [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Gleevec   safely and effectively.   See full prescribing information for Gleevec . GLEEVEC (imatinib mesylate) tablets for oral use

Sodium chloride [Baxter Healthcare Corporation]

0.9% Sodium Chloride Irrigation, USP

Lactated ringers [Baxter Healthcare Corporation]

Lactated Ringer’s Irrigationin ARTHROMATIC Plastic Container



Advertisement
Quick Search
Advertisement
Advertisement